Safety of triazole antifungals: a pharmacovigilance study from 2004 to 2021 based on FAERS

BACKGROUND: Triazole antifungals are widely used as broad-spectrum antifungal activity; however, there are many undetected and unreported adverse events (AEs). METHODS: Data from the Food and Drug Administration Adverse Event Reporting System (FAERS) from the first quarter (Q1) of 2004 to the third...

Descripción completa

Detalles Bibliográficos
Autores principales: Chai, Shuang, Zhan, Jing-Lun, Zhao, Li-Mei, Liu, Xiao-Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9761248/
https://www.ncbi.nlm.nih.gov/pubmed/36545565
http://dx.doi.org/10.1177/20420986221143266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9761248/
https://www.ncbi.nlm.nih.gov/pubmed/36545565
http://dx.doi.org/10.1177/20420986221143266

Ejemplares similares